Cleared Traditional

H200 HANNA SUCTION TREPHINE SYSTEM FOR CORNEAL SUR (K896473) - FDA 510(k) Clearance

Class I Ophthalmic device.

K896473 · Emory University School of Medicine · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1990
Decision
88d
Days
Class 1
Risk

K896473 is an FDA 510(k) clearance for the H200 HANNA SUCTION TREPHINE SYSTEM FOR CORNEAL SUR. Classified as Magnet, Permanent (product code HPN), Class I - General Controls.

Submitted by Emory University School of Medicine (Atlanta, US). The FDA issued a Cleared decision on February 9, 1990 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4445 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Emory University School of Medicine devices

Submission Details

510(k) Number K896473 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 1989
Decision Date February 09, 1990
Days to Decision 88 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 110d · This submission: 88d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HPN Magnet, Permanent
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 886.4445
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.